Cyclazocine (BioDeep_00000858895)

   


代谢物信息卡片


2,6-Methano-3-benzazocin-8-ol,3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-

化学式: C18H25NO (271.193604)
中文名称: 环佐辛
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1C2CC3=C(C1(CCN2CC4CC4)C)C=C(C=C3)O
InChI: InChI=1S/C18H25NO/c1-12-17-9-14-5-6-15(20)10-16(14)18(12,2)7-8-19(17)11-13-3-4-13/h5-6,10,12-13,17,20H,3-4,7-9,11H2,1-2H3

描述信息

D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist
D002491 - Central Nervous System Agents > D000700 - Analgesics

同义名列表

2 个代谢物同义名

2,6-Methano-3-benzazocin-8-ol,3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-; Cyclazocine



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • K L Preston, A Umbricht, J R Schroeder, M E Abreu, D H Epstein, W B Pickworth. Cyclazocine: comparison to hydromorphone and interaction with cocaine. Behavioural pharmacology. 2004 Mar; 15(2):91-102. doi: 10.1097/00008877-200403000-00001. [PMID: 15096909]
  • T Suzuki, R Shimizu, T Suganuma, J Nishino, K Tomono, M Hanano, J Watanabe. Pharmacokinetic/pharmacodynamic relationship of eptazocine, a narcotic-antagonist analgesic, in rats. Biological & pharmaceutical bulletin. 2000 Dec; 23(12):1504-10. doi: 10.1248/bpb.23.1504. [PMID: 11145186]
  • C D Soulard, S Guerif, A Payne, S G Dahl. Differential effects of fedotozine compared to other kappa agonists on diuresis in rats. The Journal of pharmacology and experimental therapeutics. 1996 Dec; 279(3):1379-85. doi: . [PMID: 8968362]
  • A Galli, E Ranaudo, L Giannini, C Costagli. Reversible inhibition of cholinesterases by opioids: possible pharmacological consequences. The Journal of pharmacy and pharmacology. 1996 Nov; 48(11):1164-8. doi: 10.1111/j.2042-7158.1996.tb03914.x. [PMID: 8961166]
  • T Kameyama, T Ohhara, Y Nakashima, Y Naito, M Z Huang, S Watanabe, T Kobayashi, H Okuyama, K Yamada, T Nabeshima. Effects of dietary vegetable oils on behavior and drug responses in mice. Biological & pharmaceutical bulletin. 1996 Mar; 19(3):400-4. doi: 10.1248/bpb.19.400. [PMID: 8924909]
  • M Gavend, M Mallaret, F Caron, G Baragatti. Antagonism of metergoline on the diuretic effect of cyclazocine and U-50488 drugs with a kappa agonist activity. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 1993; 47(8):337-44. doi: 10.1016/0753-3322(93)90083-w. [PMID: 8061255]
  • B de Costa, L Radesca, C Dominguez, L Di Paolo, W D Bowen. Synthesis and receptor binding properties of fluoro- and iodo-substituted high affinity sigma receptor ligands: identification of potential PET and SPECT sigma receptor imaging agents. Journal of medicinal chemistry. 1992 Jun; 35(12):2221-30. doi: 10.1021/jm00090a012. [PMID: 1319493]
  • R Maneckjee, R Biswas, B K Vonderhaar. Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer research. 1990 Apr; 50(8):2234-8. doi: NULL. [PMID: 2156613]
  • D R Kapusta, S Y Jones, G F DiBona. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats. The Journal of pharmacology and experimental therapeutics. 1989 Oct; 251(1):230-7. doi: NULL. [PMID: 2552076]
  • H N Bhargava, P Ramarao, A Gulati. Changes in multiple opioid receptors in regions of the brain in rats treated chronically with thyroxine. Neuropharmacology. 1989 Sep; 28(9):955-60. doi: 10.1016/0028-3908(89)90195-0. [PMID: 2554187]
  • S Takahashi, H Katagai, T Takazawa, A Matsuki, T Oyama. [Effects of modified NLA with droperidol and eptazocine and surgery on pituitary-adrenocortical function in man]. Masui. The Japanese journal of anesthesiology. 1989 Apr; 38(4):523-30. doi: . [PMID: 2724517]
  • S Benyhe, T Farkas, M Wollemann. Effect of sodium on [3H]ethylketocyclazocine binding to opioid receptors in frog brain membranes. Neurochemical research. 1989 Mar; 14(3):205-10. doi: 10.1007/bf00971311. [PMID: 2542822]
  • K M Kumor, C A Haertzen, D R Jasinski, R E Johnson. The psychopharmacologic and prolactin response after large doses of naloxone in man. Pharmacology, biochemistry, and behavior. 1988 Aug; 30(4):967-75. doi: 10.1016/0091-3057(88)90128-1. [PMID: 3227043]
  • M Gue, C Honde, X Pascaud, J L Junien, M Alvinerie, L Bueno. CNS blockade of acoustic stress-induced gastric motor inhibition by kappa-opiate agonists in dogs. The American journal of physiology. 1988 Jun; 254(6 Pt 1):G802-7. doi: 10.1152/ajpgi.1988.254.6.g802. [PMID: 2897797]
  • S Belisle, A Petit, N Gallo-Payet, D Bellabarba, J G Lehoux, S Lemaire. Functional opioid receptor sites in human placentas. The Journal of clinical endocrinology and metabolism. 1988 Feb; 66(2):283-9. doi: 10.1210/jcem-66-2-283. [PMID: 2892853]
  • H N Bhargava, P Ramarao, A Gulati. Effect of methimazole-induced hypothyroidism on multiple opioid receptors in rat brain regions. Pharmacology. 1988; 37(6):356-64. doi: 10.1159/000138489. [PMID: 2854273]
  • L A Dykstra, D E Gmerek, G Winger, J H Woods. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine. The Journal of pharmacology and experimental therapeutics. 1987 Aug; 242(2):421-7. doi: . [PMID: 3302207]
  • J D Leander, J C Hart, R L Zerbe. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels. The Journal of pharmacology and experimental therapeutics. 1987 Jul; 242(1):33-9. doi: . [PMID: 3039112]
  • P J Vaysse, E L Gardner, R S Zukin. Modulation of rat brain opioid receptors by cannabinoids. The Journal of pharmacology and experimental therapeutics. 1987 May; 241(2):534-9. doi: . [PMID: 3033219]
  • C Y Shiue, R R Teng, L Q Bai, A P Wolf, C D Arnett, E J Simon. No-carrier-added (NCA) (+/-)-N-(3-[18F]fluoropropyl)-N-normetazocine-synthesis and PET studies in a baboon. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. 1987; 14(2):119-22. doi: 10.1016/0883-2897(87)90141-3. [PMID: 3496324]
  • E J Cone, D Yousefnejad, W D Buchwald, K Kumor. Determination of ketocyclazocine in human plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry. Journal of chromatography. 1986 Nov; 383(1):158-65. doi: 10.1016/s0378-4347(00)83455-6. [PMID: 3818834]
  • T P Blackburn, K R Borkowski, J Friend, M J Rance. On the mechanisms of kappa-opioid-induced diuresis. British journal of pharmacology. 1986 Nov; 89(3):593-8. doi: 10.1111/j.1476-5381.1986.tb11160.x. [PMID: 3542107]
  • G R Slizgi, J H Ludens. Role of ADH in ethylketocyclazocine-induced diuresis: studies in the Brattleboro rat. Life sciences. 1986 Jun; 38(26):2437-40. doi: 10.1016/0024-3205(86)90613-2. [PMID: 3014247]
  • E Castanas, N Bourhim, P Giraud, F Boudouresque, P Cantau, C Oliver. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites. Journal of neurochemistry. 1985 Sep; 45(3):688-99. doi: 10.1111/j.1471-4159.1985.tb04047.x. [PMID: 2993510]
  • G R Slizgi, J H Ludens. Displacement of 3H-EKC binding by opioids in rat kidney: a correlate to diuretic activity. Life sciences. 1985 Jun; 36(23):2189-93. doi: 10.1016/0024-3205(85)90328-5. [PMID: 2860552]
  • R M Eisenberg. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists. The Journal of pharmacology and experimental therapeutics. 1985 Jun; 233(3):863-9. doi: NULL. [PMID: 2989500]
  • R Pechnick, R George, R E Poland. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists. The Journal of pharmacology and experimental therapeutics. 1985 Jan; 232(1):163-9. doi: NULL. [PMID: 2981313]
  • R Pechnick, R George, R E Poland. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3. The Journal of pharmacology and experimental therapeutics. 1985 Jan; 232(1):170-7. doi: NULL. [PMID: 2981314]
  • J P Huidobro-Toro, S Parada. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance. European journal of pharmacology. 1984 Dec; 107(1):1-10. doi: 10.1016/0014-2999(84)90084-0. [PMID: 6098480]
  • T W Smith, P Buchan. Peripheral opioid receptors located on the rat saphenous nerve. Neuropeptides. 1984 Dec; 5(1-3):217-20. doi: 10.1016/0143-4179(84)90066-0. [PMID: 6099501]
  • J D Leander. Effects of full and partial kappa agonists and mu agonists on urine output of normally hydrated rats. Neuropeptides. 1984 Dec; 5(1-3):283-6. doi: 10.1016/0143-4179(84)90083-0. [PMID: 6099514]
  • H Ensinger, L Hedler, C Schurr, K Starke. Ethylketocyclazocine decreases noradrenaline release and blood pressure in the rabbit at a peripheral opioid receptor. Naunyn-Schmiedeberg's archives of pharmacology. 1984 Nov; 328(1):20-3. doi: 10.1007/bf00496099. [PMID: 6096725]
  • G J Gwynn, E F Domino. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. II. Antinociceptive tolerance and physical dependence. The Journal of pharmacology and experimental therapeutics. 1984 Nov; 231(2):312-6. doi: NULL. [PMID: 6092614]
  • T J Cicero, D P Owens, P F Schmoeker, E R Meyer. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists. The Journal of pharmacology and experimental therapeutics. 1983 Sep; 226(3):770-5. doi: . [PMID: 6310081]
  • J D Leander. A kappa opioid effect: increased urination in the rat. The Journal of pharmacology and experimental therapeutics. 1983 Jan; 224(1):89-94. doi: . [PMID: 6294284]
  • M T Curtis, A M Lefer. Effectiveness of ethylketocyclazocine in hemorrhagic shock. Advances in shock research. 1983; 10(?):101-9. doi: NULL. [PMID: 6308972]
  • H Kosuge, M Maeda, A Tsuji. Enzyme immunoassay of cyclazocine using peroxidase as label. Journal of pharmacobio-dynamics. 1982 Jun; 5(6):373-8. doi: 10.1248/bpb1978.5.373. [PMID: 6750077]
  • G R Slizgi, J H Ludens. Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine. The Journal of pharmacology and experimental therapeutics. 1982 Mar; 220(3):585-91. doi: . [PMID: 6121047]
  • H Tanaka, S Komatsu, M Shibuya, M Maeda, A Tsuji. [Radioimmunoassay and mass fragmentographic determination of cyclazocine in human serum and urine (author's transl)]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 1981 Jun; 101(6):521-6. doi: 10.1248/yakushi1947.101.6_521. [PMID: 7310634]
  • M Maeda, A Tsuji. Radioimmunoassay of cyclazocine and stereospecificity of antibody. Journal of pharmacobio-dynamics. 1981 Mar; 4(3):167-74. doi: 10.1248/bpb1978.4.167. [PMID: 7252767]
  • J E Peterson, C T Barnick, D Benziger, M P Kullberg, R Brown, P O'Melia, S Clemans, J Edelson. Analysis of cyclazocine in plasma. Journal of pharmaceutical sciences. 1979 Nov; 68(11):1447-50. doi: 10.1002/jps.2600681130. [PMID: 512897]
  • M F Sullivan, P S Ruemmler, D R Kalkwarf. Sustained administration of cyclazocine for antagonism of morphine. Drug and alcohol dependence. 1976 Oct; 1(6):415-28. doi: 10.1016/0376-8716(76)90006-5. [PMID: 1035154]
  • S Yolles, T D Leafe, J H Woodland, F J Meyer. Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites. Journal of pharmaceutical sciences. 1975 Feb; 64(2):348-9. doi: 10.1002/jps.2600640239. [PMID: 1127596]
  • T E Hanlon, O L McCabe, C Savage, A A Kurland. A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict. International pharmacopsychiatry. 1975; 10(4):240-50. doi: 10.1159/000468200. [PMID: 765293]
  • G J Digregorio, O'Brien. Chromatographic detection of narcotic antagonists in human urine. Journal of chromatography. 1974 Dec; 101(2):424-7. doi: 10.1016/s0021-9673(00)82863-0. [PMID: 4443404]
  • R F Kaiko, C E Inturrisi. The quantitation of cyclazocine and its metabolites in human urine by use of gas-liquid chromatography. Journal of chromatography. 1974 Nov; 100(1):63-72. doi: 10.1016/s0021-9673(00)86041-0. [PMID: 4436417]
  • S J Mulé, M L Bastos, D Jukofsky. Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse. Clinical chemistry. 1974 Feb; 20(2):243-8. doi: 10.1093/clinchem/20.2.243. [PMID: 4130418]
  • S Agurell, L O Boréus, E Gordon, J E Lindgren, M Ehrnebo, U Lönroth. Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentography. The Journal of pharmacy and pharmacology. 1974 Jan; 26(1):1-8. doi: 10.1111/j.2042-7158.1974.tb12811.x. [PMID: 4150929]
  • T A Williams, K A Pittman. Pentazocine radioimmunoassay. Research communications in chemical pathology and pharmacology. 1974 Jan; 7(1):119-43. doi: NULL. [PMID: 4855777]
  • J H Woodland, S Yolles, D A Blake, M Helrich, F J Meyer. Long-acting delivery systems for narcotic antagonists. 1. Journal of medicinal chemistry. 1973 Aug; 16(8):897-901. doi: 10.1021/jm00266a007. [PMID: 4745832]
  • S J Mulé, C W Gorodetzky, T H Clements. Disposition and metabolism of 3H-cyclazocine in dogs. Advances in biochemical psychopharmacology. 1973; 8(0):503-23. doi: NULL. [PMID: 4794906]
  • C W Gorodetzky. Sensitivity of thin-layer chromatography for detection of 16 opioids, cocaine and quinine. Toxicology and applied pharmacology. 1972 Nov; 23(3):511-8. doi: 10.1016/0041-008x(72)90053-1. [PMID: 4117468]
  • P Bass, J A Kennedy, J N Wiley. Measurement of fecal output in rats. The American journal of digestive diseases. 1972 Oct; 17(10):925-8. doi: 10.1007/bf02239532. [PMID: 4538521]
  • F Medzihradsky, P S Nandhasri. Effects of some analgesics and antidepressants on the (Na + + K + )-adenosine triphosphatase from cortices of brain and kidney. Biochemical pharmacology. 1972 Aug; 21(15):2103-9. doi: 10.1016/0006-2952(72)90163-3. [PMID: 4264878]
  • K Ahmad, F Medzihradsky. The determination of benzomorphan derivatives in plasma by gas chromatography. Life sciences. Pt. 1: Physiology and pharmacology. 1971 Jun; 10(12):707-10. doi: 10.1016/0024-3205(71)90014-2. [PMID: 5556758]
  • S J Mulé, T H Clements, C W Gorodetzky. The metabolic fate of H3-cyclazocine in dogs. The Journal of pharmacology and experimental therapeutics. 1968 Apr; 160(2):387-96. doi: NULL. [PMID: 5239862]
  • S J Mulé, C W Gorodetzky. Physiologic disposition of H3-cyclazocine in nontolerant, tolerant and abstinent dogs. The Journal of pharmacology and experimental therapeutics. 1966 Dec; 154(3):632-45. doi: NULL. [PMID: 5951605]